Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population W Tassaneeyakul, N Prabmeechai, C Sukasem, T Kongpan, P Konyoung, ... Pharmacogenetics and genomics 26 (5), 225-234, 2016 | 110 | 2016 |
Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B* 13: 01 allele in the Thai population T Tempark, P Satapornpong, P Rerknimitr, N Nakkam, N Saksit, ... Pharmacogenetics and Genomics 27 (12), 429-437, 2017 | 94 | 2017 |
HLA Alleles and CYP2C9*3 as Predictors of Phenytoin Hypersensitivity in East Asians SC Su, CB Chen, WC Chang, CW Wang, WL Fan, LY Lu, R Nakamura, ... Clinical Pharmacology & Therapeutics 105 (2), 476-485, 2019 | 62 | 2019 |
Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians CW Wang, W Tassaneeyakul, CB Chen, WT Chen, YC Teng, CY Huang, ... Journal of Allergy and Clinical Immunology 147 (4), 1402-1412, 2021 | 48 | 2021 |
Genetic association of co‐trimoxazole‐induced severe cutaneous adverse reactions is phenotype‐specific: HLA class I genotypes and haplotypes C Sukasem, J Pratoomwun, P Satapornpong, J Klaewsongkram, ... Clinical Pharmacology & Therapeutics 108 (5), 1078-1089, 2020 | 34 | 2020 |
HLA-B* 13: 01 is a predictive marker of dapsone-induced severe cutaneous adverse reactions in Thai patients P Satapornpong, J Pratoomwun, P Rerknimitr, N Saksit, N Koomdee, ... Frontiers in immunology 12, 661135, 2021 | 31 | 2021 |
Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population N Saksit, W Tassaneeyakul, N Nakkam, P Konyoung, U Khunarkornsiri, ... Pharmacogenetics and Genomics 27 (7), 255-263, 2017 | 31 | 2017 |
HLA pharmacogenetic markers of drug hypersensitivity in a Thai population N Nakkam, P Konyoung, S Kanjanawart, W Tassaneeyakul Frontiers in genetics 9, 394719, 2018 | 24 | 2018 |
Comparison between the HLA-B58 : 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous
N Saksit, N Nakkam, P Konyoung, U Khunarkornsiri, W Tassaneeyakul, ... Journal of immunology research 2017, 2017 | 16 | 2017 |
Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine N Nakkam, P Konyoung, W Amornpinyo, N Saksit, S Tiamkao, ... British Journal of Clinical Pharmacology 88 (2), 773-786, 2022 | 8 | 2022 |
Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions N Nakkam, N Saksit, P Konyoung, W Amornpinyo, U Khunarkornsiri, ... Drug Metabolism and Pharmacokinetics 47, 100480, 2022 | 6 | 2022 |
HLA alleles and CYP2C9*3 as predictors of phenytoin hypersensitivity in East Asians. SSC Su ShihChi, CCB Chen ChunBing, CWC Chang WanChun, ... | | 2019 |
Research Article Comparison between the HLA-B 58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse
N Saksit, N Nakkam, P Konyoung, U Khunarkornsiri, W Tassaneeyakul, ... | | 2017 |
Causative Drugs and Pattern of Severe Cutaneous Adverse Drug Reactions in Phrae Hospital N Saksit, S Suttisai, N Piriyachananusorn, P Tiwong, W Tassaneeyakul Thai J Pharmacol; Vol 38 (1), 15, 2016 | | 2016 |
Genetic Markers for Severe Cutaneous Adverse Drug Reactions of Phenytoin W Tassaneeyakul, S Tiamkao, N Prabmeechai, P Konyoung, ... PUBLIC HEALTH GENOMICS 18, 5-5, 2015 | | 2015 |